The analysis of mechanism of Theiler's virus-induced damyelination in L* protein transgenic mice
The analysis of mechanism of Theiler's virus-induced damyelination in L* protein transgenic mice
批准号:
13670673
负责人:
ASAKURA Kunihiko
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Theiler's murine encephalomyelitis virus (TMEV) is classified into two subgroups based on the difference in biological activities. DA strain causes chronic inflammatory demyelination in the spinal cord in susceptible strains of mice. This serves as an experimental model of multiple sclerosis, human demyelinating disease in the central nervous system (CNS). The precise mechanism of persistent infection and demyelination by DA strain is yet to be elucidated. DA strain translates 17 kDa protein, designated L*, which is out of frame with the virus. To elucidate the mechanism of persistent infection of TMEV and demyelination, in this study we tried to generate transgenic mice expressing L* protein under different promoters. We generated the constructs which have L* protein cDNA under MHC class I or iNOS or chicken β-actin promoter. These constructs were injected into FVB/NJ mouse embryo. The expression of L* was not verified in vivo although robust expression of L* was observed in vitro. Therefore, we generated the immortalized macrophage cell line J774 expressing L* protein by using lentivirus vector. Macrophage is considered as the reservoir of TMEV in chronic phase of the disease. When J774 was infected with DAL*-1, which fails to synthesize L* and has attenuated demyelinating activity in the CNS, the virus failed to grow. In contrast, DAL*-1 virus was able to grow in J774 expressing L* indicating that L* is important to grow in macrophage. In addition, the mutant virus expressing epitope-tagged L* was generated and the L* expression in the CNS in acute phase of the disease was analyzed. In acute phase, L* was expressed in the CNS in both susceptible and resistant strains of mice suggesting that L* expression itself is not a determining factor of chronic infection and demyelination.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
朝倉 邦彦(分担): "21世紀の神経免疫学-展望"医歯薬出版. 207 (2001)
朝仓邦彦(撰稿人):《21 世纪的神经免疫学 - 展望》石药出版社 207(2001 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohara Y: "Effects of L^* protein of Theiler's murine encephalomyelitis virus (TMEV) on its biological activities"Journal of Kanazawa Medical University. 27・2. 108-111 (2002)
Ohara Y:“泰勒氏鼠脑脊髓炎病毒(TMEV)的L^*蛋白对其生物活性的影响”金泽医科大学学报27・2(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
朝倉 邦彦: "多発性硬化症の脱髄モデルと免疫グロブリン療法"神経免疫学. 10・2. 203-207 (2002)
朝仓邦彦:“多发性硬化症的脱髓鞘模型和免疫球蛋白治疗”《神经免疫学》10・2(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asakura K: "Epitope-tagged L^* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection"Journal of Virology. 76・24. 13049-13054 (2002)
Asakura K:“泰勒氏鼠脑脊髓炎病毒的表位标记的 L^* 蛋白在感染急性期的中枢神经系统中表达”《病毒学杂志》76·24(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohara Y et al.: "Effects of L* protein of Theiler's murine encephalomyelitis virus (TMEV) on its biological activities"J. Kanazawa Medical University. 27. 108-111 (2002)
Ohara Y等:“泰勒氏鼠脑脊髓炎病毒(TMEV)L*蛋白对其生物活性的影响”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Astrocyte protection by targeting lipid rafts
-
批准号:24591279
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:ASAKURA Kunihiko
-
依托单位:
Mechanism of action in amyloid beta passive immunization for Alzheimer's disease
-
批准号:19591016
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:ASAKURA Kunihiko
-
依托单位:
海外基金